Soluciones Parenterales
El Hospital de Angol se encuentra obligado a garantizar la disponibilidad de los fármacos que conforman el Arsenal Farmacológico, la canasta de medicamentos utilizados en manejo de patologías GES y otros que el establecimiento requiera, en términos de calidad y oportunidad, ello para otorgar una atención óptima, eficiente y de calidad a los usuarios que allí se atienden, enmarcada bajo los lineamientos Ministeriales solicitados en la Acreditación y Autogestión Hospitalaria.
7 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1075339-856-SE24 | 05-11-2024 | Farmaceutica Insuval S.A. | $3.384.360 |
| 1075339-868-SE24 | 16-10-2024 | Fresenius Kabi Chile Limitada | $910.350 |
| 1075339-847-SE24 | 11-10-2024 | Fresenius Kabi Chile Limitada | $6.740.160 |
| 1075339-851-SE24 | 11-10-2024 | B Braun Medical SpA | $2.558.500 |
| 1075339-798-SE24 | 01-10-2024 | Farmaceutica Insuval S.A. | $3.384.360 |
| 1075339-705-SE24 | 29-08-2024 | B Braun Medical SpA | $656.880 |
| 1075339-704-SE24 | 29-08-2024 | Fresenius Kabi Chile Limitada | $4.116.448 |
| 1075339-706-SE24 | 28-08-2024 | Farmaceutica Insuval S.A. | $2.256.240 |
| 1075339-671-SE24 | 02-08-2024 | Fresenius Kabi Chile Limitada | $357.000 |
| 1075339-642-SE24 | 29-07-2024 | Fresenius Kabi Chile Limitada | $1.536.528 |
| 1075339-643-SE24 | 29-07-2024 | Farmaceutica Insuval S.A. | $1.128.120 |
| 1075339-630-SE24 | 29-07-2024 | B Braun Medical SpA | $157.080 |
| 1075339-594-SE24 | 10-07-2024 | Fresenius Kabi Chile Limitada | $5.483.520 |
| 1075339-572-SE24 | 27-06-2024 | Farmaceutica Insuval S.A. | $1.128.120 |
| 1075339-531-SE24 | 11-06-2024 | Farmaceutica Insuval S.A. | $138.516 |
| 1075339-461-SE24 | 28-05-2024 | Farmaceutica Insuval S.A. | $1.128.120 |
| 1075339-354-SE24 | 25-04-2024 | B Braun Medical SpA | $104.720 |
| 1075339-353-SE24 | 24-04-2024 | Fresenius Kabi Chile Limitada | $4.554.606 |
| 1075339-276-SE24 | 22-03-2024 | Farmaceutica Insuval S.A. | $1.128.120 |
| 1075339-277-SE24 | 22-03-2024 | Fresenius Kabi Chile Limitada | $3.875.592 |
| 1075339-141-SE24 | 13-02-2024 | Farmaceutica Insuval S.A. | $1.692.180 |
| 1075339-139-SE24 | 13-02-2024 | B Braun Medical SpA | $612.850 |
| 1075339-142-SE24 | 13-02-2024 | Fresenius Kabi Chile Limitada | $6.398.392 |
| 1075339-47-SE24 | 18-01-2024 | Fresenius Kabi Chile Limitada | $3.477.180 |
| 1075339-44-SE24 | 17-01-2024 | B Braun Medical SpA | $2.768.226 |
| 1075339-9-SE24 | 12-01-2024 | Farmaceutica Insuval S.A. | $3.384.360 |
| 1075339-880-SE23 | 19-12-2023 | Fresenius Kabi Chile Limitada | $214.200 |
| 1075339-881-SE23 | 19-12-2023 | Farmaceutica Insuval S.A. | $1.128.120 |
| 1075339-859-SE23 | 07-12-2023 | Fresenius Kabi Chile Limitada | $2.948.820 |
| 1075339-843-SE23 | 17-11-2023 | Laboratorio Sanderson S.A. | $1.204.351 |
| 1075339-776-SE23 | 17-11-2023 | B Braun Medical SpA | $3.070.200 |
| 1075339-804-SE23 | 17-11-2023 | B Braun Medical SpA | $220.626 |
| 1075339-805-SE23 | 13-11-2023 | Farmaceutica Insuval S.A. | $1.692.180 |
| 1075339-842-SE23 | 13-11-2023 | B Braun Medical SpA | $4.069.800 |
| 1075339-803-SE23 | 09-11-2023 | Fresenius Kabi Chile Limitada | $3.886.540 |
| 1075339-772-SE23 | 02-11-2023 | Laboratorio Sanderson S.A. | $673.064 |
| 1075339-692-SE23 | 04-10-2023 | B Braun Medical SpA | $191.209 |
| 1075339-694-SE23 | 04-10-2023 | Farmaceutica Insuval S.A. | $1.692.180 |
| 1075339-693-SE23 | 27-09-2023 | Fresenius Kabi Chile Limitada | $3.151.120 |
| 1075339-633-SE23 | 28-08-2023 | Laboratorio Sanderson S.A. | $252.399 |
| 1075339-634-SE23 | 28-08-2023 | B Braun Medical SpA | $367.710 |
| 1075339-635-SE23 | 28-08-2023 | Farmaceutica Insuval S.A. | $1.128.120 |
| 1075339-632-SE23 | 23-08-2023 | Fresenius Kabi Chile Limitada | $2.457.112 |
| 1075339-649-SE23 | 23-08-2023 | Fresenius Kabi Chile Limitada | $1.832.600 |
| 1075339-591-SE23 | 17-08-2023 | Farmaceutica Insuval S.A. | $1.128.120 |
| 1075339-559-SE23 | 02-08-2023 | Fresenius Kabi Chile Limitada | $214.200 |
| 1075339-560-SE23 | 02-08-2023 | Laboratorio Sanderson S.A. | $504.798 |
| 1075339-578-SE23 | 02-08-2023 | B Braun Medical SpA | $191.209 |
| 1075339-584-SE23 | 02-08-2023 | Fresenius Kabi Chile Limitada | $859.180 |
| 1075339-522-SE23 | 13-07-2023 | Fresenius Kabi Chile Limitada | $523.600 |
| 1075339-515-SE23 | 07-07-2023 | Fresenius Kabi Chile Limitada | $4.212.600 |
| 1075339-451-SE23 | 06-07-2023 | Fresenius Kabi Chile Limitada | $1.572.228 |
| 1075339-452-SE23 | 06-07-2023 | Farmaceutica Insuval S.A. | $1.128.120 |
| 1075339-450-SE23 | 06-07-2023 | B Braun Medical SpA | $269.749 |
| 1075339-431-SE23 | 16-06-2023 | Fresenius Kabi Chile Limitada | $3.370.080 |
| 1075339-416-SE23 | 06-06-2023 | Farmaceutica Insuval S.A. | $1.128.120 |
| 1075339-352-SE23 | 26-05-2023 | B Braun Medical SpA | $328.583 |
| 1075339-351-SE23 | 26-05-2023 | Fresenius Kabi Chile Limitada | $2.527.560 |
| 1075339-345-SE23 | 15-05-2023 | Laboratorio Sanderson S.A. | $1.751.799 |
| 1075339-286-SE23 | 28-04-2023 | Farmaceutica Insuval S.A. | $1.128.120 |
| 1075339-281-SE23 | 25-04-2023 | Fresenius Kabi Chile Limitada | $5.827.192 |
| 1075339-282-SE23 | 25-04-2023 | B Braun Medical SpA | $157.080 |
| 1075339-205-SE23 | 20-03-2023 | B Braun Medical SpA | $250.043 |
| 1075339-214-SE23 | 20-03-2023 | B Braun Medical SpA | $78.540 |
| 1075339-213-SE23 | 20-03-2023 | Fresenius Kabi Chile Limitada | $1.455.132 |
| 1075339-151-SE23 | 21-02-2023 | Fresenius Kabi Chile Limitada | $221.340 |
| 1075339-104-SE23 | 09-02-2023 | Fresenius Kabi Chile Limitada | $2.527.560 |
| 1075339-107-SE23 | 09-02-2023 | Fresenius Kabi Chile Limitada | $428.400 |
| 1075339-106-SE23 | 09-02-2023 | Farmaceutica Insuval S.A. | $2.820.300 |
| 1075339-65-SE23 | 20-01-2023 | Fresenius Kabi Chile Limitada | $1.348.032 |
| 1075339-9-SE23 | 14-01-2023 | Farmaceutica Insuval S.A. | $2.256.240 |
| 1075339-7-SE23 | 12-01-2023 | B Braun Medical SpA | $191.209 |
| 1075339-1076-SE22 | 26-12-2022 | Fresenius Kabi Chile Limitada | $913.920 |
| 1075339-1064-SE22 | 20-12-2022 | B Braun Medical SpA | $671.731 |
| 1075339-992-SE22 | 13-12-2022 | Farmaceutica Insuval S.A. | $2.256.240 |
| 1075339-991-SE22 | 13-12-2022 | B Braun Medical SpA | $132.376 |
| 1075339-990-SE22 | 12-12-2022 | Fresenius Kabi Chile Limitada | $110.670 |
Fuente original:ficha mercadopublico.cl
